ID
30399
Description
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00893477
Lien
https://clinicaltrials.gov/show/NCT00893477
Mots-clés
Versions (1)
- 02/06/2018 02/06/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
2 juin 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Lymphoma NCT00893477
Eligibility Lymphoma NCT00893477
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT00893477
- StudyEvent: Eligibility
C0882818 (UMLS CUI [1,2])
C0079611 (UMLS CUI [1,3])
C1301142 (UMLS CUI [1,4])
C0432516 (UMLS CUI [1,2])
C0432516 (UMLS CUI [1,2])
C0332300 (UMLS CUI [1,2])
C1511341 (UMLS CUI [1,3])
C0005558 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0205251 (UMLS CUI [1,2])
C0443268 (UMLS CUI [1,2])
C1301886 (UMLS CUI [1,3])
C0456389 (UMLS CUI [1,4])
C3273930 (UMLS CUI [2,1])
C1517067 (UMLS CUI [2,2])
C1301886 (UMLS CUI [2,3])
C0456389 (UMLS CUI [2,4])
C1706867 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,3])
C1848823 (UMLS CUI [2])
C0859328 (UMLS CUI [3])
C0038002 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0302149 (UMLS CUI [1,2])
C1393567 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
C0019158 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2])
C0038317 (UMLS CUI [3])
C1522449 (UMLS CUI [4])